Dextrothyroxine (trade name Choloxin) is a dextrorotary isomer of thyroxine.[1] It saw research as a cholesterol-lowering drug[2] but was pulled due to cardiac side-effects. It increases hepatic lipase which in turn improves utilization of triglycerides and decreases levels of lipoprotein(a) in blood serum.[3]
Clinical data | |
---|---|
Trade names | Choloxin |
Other names | D-3,5,3',5'-tetraiodothyronine |
AHFS/Drugs.com | Multum Consumer Information |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
ChEBI |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.000.094 |
Chemical and physical data | |
Formula | C15H11I4NO4 |
Molar mass | 776.874 g·mol−1 |
3D model (JSmol) |
|
| |
|